Cuvitru-4 (Human Normal Immunoglobulin Vials) 4 g/20ml

Cuvitru-4 is a human normal immunoglobulin solution in 4 g/20ml vials, used for immune support. This 1-vial pack provides a ready-to-use option for subcutaneous administration. Store below 25°C to maintain stability. Ideal for patients requiring regular immunoglobulin therapy.

Strength

4 g/20ml

Pack Size

Storage

Below 25°C

Manufacturer / TM Owner

Takeda Pharma AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Human normal immunoglobulin like Cuvitru-4 is commonly used to support immune function in individuals with weakened immune systems. It may help manage conditions where the body lacks sufficient antibodies, providing passive immunity. Often prescribed for primary immunodeficiency disorders or after exposure to certain infections.

Side Effects

Cuvitru-4 works by supplementing antibodies in the bloodstream, which may help reduce the frequency of infections. Users often report improved energy levels and fewer illness episodes over time. The effects vary by individual and depend on consistent use as directed.

Precautions & Warnings

Store Cuvitru-4 below 25°C and protect from freezing. Inspect the vial for particles or discoloration before use. Always follow healthcare provider instructions for administration and disposal. Keep out of reach of children and pets.

Avoid Interactions

Cuvitru-4 may interact with live vaccines, potentially reducing their effectiveness. Avoid mixing with other medications in the same syringe or infusion line. Consult a healthcare provider before combining with other treatments, especially those affecting the immune system.

Frequently Asked Questions

Cuvitru-4 is used to support immune function in people with primary immunodeficiency or those who need antibody replacement therapy.

It is typically given as a subcutaneous injection under medical supervision or as directed by a healthcare provider.

Cuvitru-4 is available by prescription; consult a licensed pharmacy or healthcare provider for purchase options.

Store below 25°C and avoid freezing; do not use if the solution is cloudy or contains particles.

Common side effects may include redness or swelling at the injection site; report persistent issues to a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.